V110 clinical trials

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Children and Adolescents With Increased Risk of Pneumococcal Disease.

This study is testing a new vaccine (V116) to see how well it works and if it's safe for children and teens who are more likely to get sick from certain bacteria called pneumococcus. It compares the new vaccine to existing ones.